Two colleagues began engineering RNA-guided nucleases before CRISPR-Cas9 was ever used for gene editing. We visited them in Israel to learn about their startup, the booming gene editing industry, and how they might just beat CRISPR at its own game. 

Yoel: <a href='https://www.linkedin.com/in/yoelshiboleth'>linkedin.com/in/yoelshiboleth</a>

Music from: <a href='https://freesound.org/'>https://freesound.org/</a>

Two colleagues began engineering RNA-guided nucleases before CRISPR-Cas9 was ever used for gene editing. We visited them in Israel to learn about their startup, the booming gene editing industry, and how they might just beat CRISPR at its own game. Yoel: linkedin.com/in/yoelshiboleth Music from: https://freesound.org/

Two colleagues began engineering RNA-guided nucleases before CRISPR-Cas9 was ever used for gene editing. We visited them in Israel to learn about their startup, the booming gene editing industry, and how they might just beat CRISPR at its own game.&nbsp;

Yoel:&nbsp;<a href="https://www.linkedin.com/in/yoelshiboleth" rel="noopener noreferrer">linkedin.com/in/yoelshiboleth</a>

Music from: <a href="https://freesound.org/" rel="noopener noreferrer">https://freesound.org/</a>

The Future of Gene Editing and How to Beat CRISPR with TargetGene CEO Yoel Shiboleth and COO Dan Weinthal

Informative and fun interviews with technology and business thought leaders in Biotech.

Share The Future of Gene Editing and How to Beat CRISPR with TargetGene CEO Yoel Shiboleth and COO Dan Weinthal

Sign up to save your podcasts

The Future of Gene Editing and How to Beat CRISPR with TargetGene CEO Yoel Shiboleth and COO Dan Weinthal

The Future of Gene Editing and How to Beat CRISPR with TargetGene CEO Yoel Shiboleth and COO Dan Weinthal